Medpace Holdings, Inc. (MEDP)

591.29USD -0.35% (-2.10)

Over 6M: +23.6%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

400 500 600
Mar Apr May Jun Jul Aug Sep

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

7.5
SBC / sales 0.76%
ROIC —
OE margin 24.6%
Oper. margin 21.0%
Accruals -12.7%
FCF margin 25.4%
ROA 23.9%
ROCE 93.8%
ROE 113.3%
OCF margin 27.1%
OCF / EBIT 1.3×
Gross margin —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

6.7
EV/OE 23.4×
EV/EBIT 27.5×
FCF yield 4.3%
P/E 33.6×
EV/Sales 5.8×
P/B 38.1×
P/C 32.9×
Div. yield —
EV/GP —
Fwd P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

8.8
RPO / sales 1.3×
RPO growth 0.0%
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

8.5
ND/EBITDA 0.031
Interest cover —
Debt / Eq 0.0×
Debt payback 0.0 yr
F-score 7.7 pts
Payout 0.0%
Quick ratio 0.73×
Cash / Debt —
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.8
Sales/sh Y/Y +35.2%
Sales CAGR 4Y +22.0%
EPS CAGR 4Y +33.5%
EBIT CAGR +23.5%
EBIT Y/Y +22.2%
EPS Y/Y +27.4%
Sales Q/Q +17.2%
Div. growth —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.